Cherry Zoap Autoflower is a modern autoflowering variety developed through the crossing of Zoap with Ruderalis genetics. Its specific origins remain undocumented, with no definitive breeder information available to establish its creation date or primary cultivation goals. As a descendant of the Zoap line crossed with ruderalis, this strain is engineered for automated flowering, reaching maturity in exactly 77 days. It is cultivated in both indoor and outdoor environments with an easy difficulty rating, though cultivators should anticipate a low yield from this particular variety.

The chemical profile of Cherry Zoap Autoflower is confirmed to express a complex array of thirteen terpenes, ranging from caryophyllene as the dominant compound to camphene as the tertiary baseline. This sequence, including limonene, myrcene, pinene, linalool, humulene, terpinolene, beta-pinene, bisabolol, nerolidol, ocimene, and guaiol, forms a robust aromatic structure. Users experience a sensory profile defined by these constituents, which provide the distinct scent and flavor characteristics inherent to the cultivar.

As a THC-dominant variety, Cherry Zoap Autoflower delivers consistent psychotropic effects that are characterized as relaxed, happy, and uplifted. These qualities make the strain a functional choice for those seeking relief from stress and pain, while also serving as an aid for sleep. At this time, there are no recorded notable offspring for this strain, meaning its genetic legacy remains singularly defined by the primary cross.